Global Bone Cement Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Type (Polymethyl Methacrylate, Calcium Phosphate, Glass Polyalkenoate), By Application (Arthroplasty, Kyphoplasty, Vertebroplasty, Others), By Antibiotic Type (Antibiotic, Non-Antibiotic), By Viscosity (High, Medium & Low), By End Users (Hospitals And Clinics, Ambulatory Surgical Centers), And By Geography - Forecasts From 2019 To 2024

Published:  Nov 2022 Report Code: KSI061611894 Pages: 111

The global bone cement market is expected to grow at a CAGR of 6.33% over the forecast period to reach US$683.069 million by 2027 from US$444.417 million in 2020. Bone cement refers to a synthetic biomaterial obtained from mixing polymethyl methacrylate, calcium phosphate, or glass polyalkenoate powder with a liquid monomer. The cement has a super gluing feature owing to which it has high applicability in orthopedical surgical procedures such as hip, knee, and joint replacement. The self-healing nature and the ability to work as artificial joints are what drives the demand for bone cement in the medical field. The growing prevalence of fatal injuries, accidents and orthopedical surgical producers coupled with the rising old age population has provided more growth opportunities to the global cement market. For instance, according to the data provided by the US Bureau of Labor Statistics, in 2019, the number of fatal work injuries that occurred in the US stood at 5,333 which showed a significant increase of 10.3% in comparison to the 4,836 injuries that occurred in 2015. With such an increase in fatal injuries, the scope of bone cement usage for the treatment of any bone-related injury also increases, thereby boosting the market demand as well the market growth of the global bone cement market during the forecast period.

Based on type, the global bone cement market is segmented into polymethyl methacrylate, calcium phosphate, and glass polyalkenoate. The polymethyl methacrylate segment is expected to grow at a relatively higher rate during the forecast period of the global bone cement market. Polymethyl Methacrylate has rich mechanical strength, minimal toxicity, and provides improved self-curing properties owing to which it has high applicability during joint prostheses fixation. Hence, acting as a space filler between the bone and the implant PMMA bone cement improves the fixation of the implant. The high-performance features of polymethyl acrylate bone cement coupled with its cost-effectiveness and high durability are expected to increase its demand for joint prostheses surgeries in the future, thereby, boosting its segment growth as well as the overall global bone cement market growth during the forecast period.

The rapid increase in the number of orthopedic surgeries is driving the market demand for bone cement. Bone cement has high applicability in orthopedical surgical procedures where the damaged bone part is replaced with a prosthesis, and to hold the prosthesis in its place, bone cement is used. The number of orthopedical surgical procedures has shown a significant increase over the years owing to the growing number of joint & bone pain in people, especially in old age coupled with growing cases of osteoarthritis and road accidents. For instance, according to the annual report by the American Academy of Orthopedic Surgeons, in 2021, the number of knee and hip bone replacement surgeries stood at 2.4 million in the US which showed an increase of 18.3% in comparison to the number of surgical procedures conducted in 2020. Furthermore, according to the 2022 annual report of the Australia Orthopaedic Association National Joint Replacement Surgery Registry, in 2021, the total number of joint replacement surgeries reported in 2021 Australia stood at 1.85 million with which knee replacement held the largest share of 68,466 followed by hips replacement with 52,787. The overall increase in joint replacement surgeries in 2021 was 7.6% in comparison to 2020’s joint replacement surgical volume. With such an increase in the number of orthopedic surgical procedures, the demand and consumption of bone cement to act as a gap filler in bones are also anticipated to increase, thereby providing a positive outlook for the growth of the global bone cement market during the forecast period. However, the extensive cost incurred in preparing bone cement coupled with implant complications is projected to hamper the growth of the global cement market during the forecast period.

Recent development and expansion

  • In May 2022, KPower Bhd launched a synthetic bone cement product namely “Proteomax”, which is the first halal-certified synthetic bone cement in Malaysia. The bone cement contains a high mixture of calcium phosphate and will be used for orthopedic surgeries and treating fatal bone injuries.
  • In January 2022, SetBone Medical Ltd. announced investments of US$1.6million for the development of the company’s patent-pending bone cement which will not contain any toxic monomers and their first usage will be in treating vertebral compression fractures.
  • In December  2020, Icotec ag entered into a strategic collaboration with G-21 for the distribution of their bone cement products along with icotec’s VADER Pedicle screw system in the United States market.

Covid 19

COVID-19 led to global lockdown, and to prevent the widespread of the virus, various restrictions and regulations were implemented. All such regulations decreased the scale of various surgical procedures such as orthopedics owing to which the demand and consumption of bone cement decreased in 2020. For instance, according to the online survey conducted by the University of British Columbia and the British Columbia Orthopedic Association from June to August 2020, the backlog of orthopedic surgical cases in British Columbia stood at 32,400 due to the cancellation of surgical procedures, and the number of trauma cases also saw a significant decline due to the COVID-pandemic. Such a decrease in orthopedical surgical procedures and trauma cases negatively impacted the bone cement demand thereby, restraining its market growth on a global scale. However, with the ease of COVID restrictions, the number of surgical procedures related to orthopedics is witnessing a steady rise, thereby providing a positive outlook for the global bone cement market.

Segmentation

  • By Type
    • Polymethyl Methacrylate
    • Calcium Phosphate
    • Glass Polyalkenoate
  • By Viscosity
    • Low
    • Medium
    • High
  • By Antibiotics Type
    • Gentamicin
    • Tobramycin
    • Cefuroxime
  • By Application
    • Arthroplasty
    • Kyphoplasty
    • Vertebroplasty
    • Others
  • By End-User
    • Hospitals & Clinics
    • Ambulatory Surgical Center
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • Israel
      • United Arab Emirates
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Indonesia
      • Thailand
      • Taiwan
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the bone cement market size by 2024?
A1. The bone cement market is projected to reach a market size of US$704.854 million in 2024.
 
Q2. What is the size of global bone cement market?
A2. Bone Cement market was valued at US$479.538 million in 2018.
 
Q3. What are the growth prospects for bone cement market?
A3. The bone cement market is projected to grow at a CAGR of 6.63% during the forecast period.
 
Q4. What factors are anticipated to drive the bone cement market growth?
A4. The rise in the geriatric population who are more susceptible to the fractures and associated injury and often require joint replacement surgery is driving the growth of the bone cement market.
 
Q5. How is the global bone cement market segmented?
A5. The bone cement market has been segmented based on type, application, antibiotic type, viscosity, end-user, and geography.

1. INTRODUCTION

1.1. Market Overview

1.2. Covid-19 Scenario

1.3. Market Definition

1.4. Market Segmentation

 

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

 

3. EXECUTIVE SUMMARY

3.1. Research Highlights

 

4. MARKET DYNAMICS

4.1. Market Driver

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of End-Users

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

 

5. GLOBAL BONE CEMENT MARKET, BY TYPE

5.1. Introduction

5.2. Polymethyl Methacrylate

5.3. Calcium Phosphate

5.4. Glass Polyalkenoate

 

6. GLOBAL BONE CEMENT MARKET, BY VISCOSITY

6.1. Introduction

6.2. High

6.3. Medium

6.4. High

 

7. GLOBAL BONE CEMENT MARKET, BY ANTIBIOTICS TYPE

7.1. Introduction

7.2. Gentamicin

7.3. Tobramycin

7.4. Cefuroxime

 

8. GLOBAL BONE CEMENT MARKET, BY APPLICATION

8.1. Arthroplasty

8.2. Kyphoplasty

8.3. Vertebroplasty

8.4. Others

 

9. GLOBAL BONE CEMENT MARKET, BY END-USER

9.1. Hospitals & Clinics

9.2. Ambulatory Surgical Centre

 

10. GLOBAL BONE CEMENT MARKET, BY GEOGRAPHY

10.1. Introduction

10.2. North America

10.2.1. USA

10.2.2. Canada

10.2.3. Mexico

10.3. South America

10.3.1. Brazil

10.3.2. Argentina

10.3.3. Others

10.4. Europe

10.4.1. Germany

10.4.2. France

10.4.3. United Kingdom

10.4.4. Italy

10.4.5. Spain

10.4.6. Others

10.5. Middle East and Africa

10.5.1. Saudi Arabia

10.5.2. Israel

10.5.3. United Arab Emirates

10.5.4. Others

10.6. Asia Pacific

10.6.1. China

10.6.2. Japan

10.6.3. South Korea

10.6.4. India

10.6.5. Australia

10.6.6. Indonesia

10.6.7. Thailand

10.6.8. Taiwan

10.6.9. Others

 

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

11.1. Major Players and Strategy Analysis

11.2. Emerging Players and Market Lucrativeness

11.3. Mergers, Acquisitions, Agreements, and Collaborations

11.4. Vendor Competitiveness Matrix

 

12. COMPANY PROFILES

12.1. DePuy Synthesis (Part of Johnson & Johnson)

12.2. Stryker

12.3. Zimmer Biomet

12.4. Tecres SpA

12.5. Synimed Synergie Ingénierie Médicale S.A.R.L

12.6. Olympus Corporation

12.7. Heraeus holdings

12.8. Teknimed

12.9. Exactech Inc.

12.10. DJO, LLC

DePuy Synthesis (Part of Johnson & Johnson)

Stryker

Zimmer Biomet

Tecres SpA

Synimed Synergie Ingénierie Médicale S.A.R.L

Olympus Corporation

Heraeus holdings

Teknimed

Exactech Inc.

DJO, LLC

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us